| http://www.w3.org/ns/prov#value | - Despite a great deal of R&D efforts at many companies as well as many therapies already on the market for asthma, CF, COPD, and other respiratory illnesses, unmet medical needs still remain. ???We???re excited about the potential our biologics may have to impact this disease area,??? Perry says.
|
